Skip to content
Site Tools
Narrow screen resolution Wide screen resolution Auto-adjust screen resolution Increase font size Decrease font size Default font size
You are here: Home arrow Books arrow Cell biology arrow Design of Caspase Inhibitors as Potential Clinical Agents (2008)
Design of Caspase Inhibitors as Potential Clinical Agents (2008) PDF Print E-mail
User Rating: / 0
PoorBest 
Written by bioXplorer   
Oct 31, 2008 at 04:08 PM
Image

Title: Design of Caspase Inhibitors as Potential Clinical Agents

Author(s): Tom O'Brien, Steven D. Linton

Series: Enzyme Inhibitors

Publisher: CRC

ISBN: 1420045407

Publication: 2008

Pages: 327

Description: Caspases represent one of the most specific protease families described to date. As caspase family members are involved in pro-inflammatory responses, inhibition of caspase activity represents a novel yet core approach to disease treatment. Design of Caspase Inhibitors as Potential Clinical Agents discusses the role of cysteine aspartyl proteases (caspases) in inducing cell death. It reviews recent efforts to develop small molecular inhibitors that are capable of modulating caspase activity. The text also examines the difficulties encountered in transitioning small molecular inhibitors from the lab to clinical use, and discusses how these challenges can best be overcome to allow continued progress.

Download (8 MB):

Must be registered to view link!


Add as favourites (0) | Views: 307

  Be first to comment this article

Only registered users can write comments.
Please login or register.

Powered by AkoComment Tweaked Special Edition v.1.4.6
AkoComment © Copyright 2004 by Arthur Konze - www.mamboportal.com
All right reserved

Recomended Sites

Who's Online

We have 23 guests online and 9 members online

Login

Username

Password

Remember me
Password Reminder
No account yet? Create one